303 related articles for article (PubMed ID: 27488574)
1. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
Stark JG; Engelking D; McMahen R; Sikes C
Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
Stark JG; Engelking D; McMahen R; Sikes C
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):216-222. PubMed ID: 27936898
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
4. An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
Marraffino A; Sikes CR; Laage T; Volosov A; Hart A; Engelking D
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):15-20. PubMed ID: 31295008
[No Abstract] [Full Text] [Related]
5. Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
Weisler RH; Stark JG; Sikes C
Clin Pharmacol Drug Dev; 2018 Feb; 7(2):160-167. PubMed ID: 28544344
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
Sikes CR; McMahen RL; Stark JG; Engelking D
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):29-35. PubMed ID: 28933918
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults.
Newcorn JH; Stark JG; Adcock S; McMahen R; Sikes C
Clin Ther; 2017 Aug; 39(8):1695-1705. PubMed ID: 28760535
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults.
Childress A; Stark JG; McMahen R; Engelking D; Sikes C
Clin Pharmacol Drug Dev; 2018 Feb; 7(2):151-159. PubMed ID: 28544581
[TBL] [Abstract][Full Text] [Related]
9. A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Childress A; Newcorn J; Stark JG; McMahen R; Tengler M; Sikes C
J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):505-12. PubMed ID: 27228207
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.
Ermer JC; Shojaei A; Pennick M; Anderson CS; Silverberg A; Youcha SH
Curr Med Res Opin; 2007 May; 23(5):1067-75. PubMed ID: 17519073
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of AR19, an Immediate-Release Amphetamine Sulfate Formulation Designed to Deter Manipulation for Administration Via Nonoral Routes: Bioequivalence to Reference Racemic Amphetamine Sulfate, Dose Proportionality, and Food Effect.
Caras S; Sharpe T
J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):69-80. PubMed ID: 31809216
[No Abstract] [Full Text] [Related]
12. A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults.
Sikes C; Stark JG; McMahen R; Engelking D
J Atten Disord; 2020 Feb; 24(3):414-419. PubMed ID: 29192549
[No Abstract] [Full Text] [Related]
13. Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults.
Clausen SB; Read SC; Tulloch SJ
CNS Spectr; 2005 Dec; 10(12 Suppl 20):6-15. PubMed ID: 16344836
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
Disanto AR; Golden G
Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515
[TBL] [Abstract][Full Text] [Related]
15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
16. Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.
Haffey MB; Buckwalter M; Zhang P; Homolka R; Martin P; Lasseter KC; Ermer JC
Postgrad Med; 2009 Sep; 121(5):11-9. PubMed ID: 19820270
[TBL] [Abstract][Full Text] [Related]
17. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder.
Ilic K; Kugler AR; Yan B; McNamara N
CNS Drugs; 2022 Jan; 36(1):71-81. PubMed ID: 34826114
[TBL] [Abstract][Full Text] [Related]
19. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension.
Pardo A; Kando JC; King TR; Rafla E; Herman BK
CNS Spectr; 2020 Dec; 25(6):774-781. PubMed ID: 31964449
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects.
Damle B; Duczynski G; Jeffers BW; Crownover P; Coupe A; LaBadie RR
Clin Ther; 2014 Feb; 36(2):236-44. PubMed ID: 24447534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]